Observational studyBMC geriatrics2026
An observational diagnostic accuracy study comparing the urine dipstick with a consensus-based reference standard for the diagnosis of urinary tract infections in older adults.
Observational study in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe urine dipstick is widely used to screen for urinary tract infection (UTI) in daily practice. However, in older adults, especially women, its reliability is limited by the high prevalence of asymptomatic bacteriuria and leukocyturia. Recently, a consensus-based reference standard was introduced to classify patients based on the likelihood of UTI. Using this standard, we assessed the diagnostic accuracy of the urine dipstick in older adults.
methodsWe performed an observational study using prospectively collected data from two ongoing studies. We included adults aged ≥ 60 years with clinically suspected UTI who underwent dipstick testing, urine flow cytometry, and urine culture during the same episode. The Roche COMBUR-7 urine dipstick served as the index test, and episodes were classified using the consensus-based reference standard. We evaluated all possible dipstick thresholds and their combinations, calculating sensitivity, specificity, predictive values, and likelihood ratios using Generalized Estimating Equations to account for multiple episodes per participant. Receiver operating characteristic analysis was performed to determine the optimal balance between sensitivity and specificity.
resultsWe included 368 episodes from 199 participants (mean age 73.8 years; 77.9% women). Dipstick sensitivity was 93.6% (95% CI 90.1%-95.9%) and specificity was 58.6% (95% CI 45.4%-70.6%) for the conventional threshold of nitrite + and/or leukocyte esterase ≥ 1 + . A higher threshold, "total of ≥ 2 + " (leukocyte esterase ≥ 2 + or nitrite positive with leukocyte esterase ≥ 1 +) improved performance, yielding a sensitivity of 82.2% (95% CI 77.0%-86.4%) and a specificity of 75.7% (95% CI 61.6%-85.8%). With this threshold, the positive likelihood ratio improved from 2.3 (95% CI 1.76-3.06) to 3.4 (95% CI 2.0-6.1).
conclusionsIn older adults with suspected UTI, urine dipstick testing demonstrates limited diagnostic performance. Current thresholds yield high sensitivity but poor specificity, which may contribute to unnecessary antimicrobial treatment. Given the high prevalence of asymptomatic bacteriuria in older adults, a higher threshold of "total of ≥ 2 + " (either LE ≥ 2 + , or nitrite + combined with LE ≥ 1 +) may improve diagnostic accuracy and be considered when assessing patients ≥ 60 years old for antibiotic therapy. Prospective studies are needed to confirm this recommendation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.